Macrophage reprogramming by the ultraviolet filter benzophenone-1 promotes malignant phenotypes in breast cancer cells: integrated computational and experimental evidence
- 1Department of Breast Disease Center, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China
- 2Hebei Medical University, Shijiazhuang, China
- 3College of Veterinary Medicine, Shandong Agricultural University, Tai’an, China
Abstract
Background: Benzophenone-1 (BP-1) is a benzophenone ultraviolet absorber used in cosmetic and personal care products. Although BP-1 exhibits estrogenic activity, its broader effects in breast cancer remain unclear. This study investigated the molecular and cellular responses associated with BP-1 exposure.
Methods: Integrated computational analyses were used to identify core targets and determine their cellular distribution. Molecular modeling evaluated BP-1–target binding. Macrophage polarization and secretion were assessed by immunofluorescence, RT-qPCR, enzyme-linked immunosorbent assay, and western blotting. The effects of macrophage-conditioned medium on breast cancer cells were examined using proliferation, migration, invasion, and epithelial-mesenchymal transition assays.
Results: PLAUR was identified as the core BP-1-related candidate and was prominently expressed in macrophages. BP-1 increased expression of uPAR, the protein encoded by PLAUR, and shifted macrophages toward an M2-like phenotype. Conditioned medium from these macrophages enhanced malignant phenotypes in breast cancer cells.
Conclusion: This study identifies a macrophage-associated response to BP-1 exposure that may contribute to malignant phenotypes in estrogen receptor-positive breast cancer, with PLAUR/uPAR as a candidate mediator. These findings provide a basis for further mechanistic and in vivo studies.
Related
- Host Metabolic Reprogramming Defines Macrophage Antifungal Activity Against Cryptococcus neoformans
- Mesaconate-Based Polyester Nanoparticles Reveal How Metabolite Isomerism Shapes Polymer Behavior, Macrophage Reprogramming, and Systemic Immunomodulation
- PPARγ brakes cytosolic DNA-induced macrophage inflammation by super-enhancer metabolic reprogramming
- Lactate-Driven Biphasic Reprogramming of Macrophage Immune Responses
- Nanotherapeutic macrophage reprogramming through immunometabolic and microbial modulation for sepsis treatment.
BibTeX
@article{he2026macrophage,
title = {{Macrophage reprogramming by the ultraviolet filter benzophenone-1 promotes malignant phenotypes in breast cancer cells: integrated computational and experimental evidence}},
author = {Binglu He and Longying Ding and Xiaolu Yang and Tianqi Zhang and Li Ma},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
month = oct,
doi = {10.3389/fmolb.2026.1946836},
url = {https://doi.org/10.3389/fmolb.2026.1946836},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Macrophage reprogramming by the ultraviolet filter benzophenone-1 promotes malignant phenotypes in breast cancer cells: integrated computational and experimental evidence
AU - Binglu He
AU - Longying Ding
AU - Xiaolu Yang
AU - Tianqi Zhang
AU - Li Ma
PY - 2026
DA - 2026/10/13
JO - Frontiers in Molecular Biosciences
DO - 10.3389/fmolb.2026.1946836
UR - https://doi.org/10.3389/fmolb.2026.1946836
AB - Background: Benzophenone-1 (BP-1) is a benzophenone ultraviolet absorber used in cosmetic and personal care products. Although BP-1 exhibits estrogenic activity, its broader effects in breast cancer remain unclear. This study investigated the molecular and cellular responses associated with BP-1 exposure. Methods: Integrated computational analyses were used to identify core targets and determine their cellular distribution. Molecular modeling evaluated BP-1–target binding. Macrophage polarization and secretion were assessed by immunofluorescence, RT-qPCR, enzyme-linked immunosorbent assay, and western blotting. The effects of macrophage-conditioned medium on breast cancer cells were examined using proliferation, migration, invasion, and epithelial-mesenchymal transition assays. Results: PLAUR was identified as the core BP-1-related candidate and was prominently expressed in macrophages. BP-1 increased expression of uPAR, the protein encoded by PLAUR, and shifted macrophages toward an M2-like phenotype. Conditioned medium from these macrophages enhanced malignant phenotypes in breast cancer cells. Conclusion: This study identifies a macrophage-associated response to BP-1 exposure that may contribute to malignant phenotypes in estrogen receptor-positive breast cancer, with PLAUR/uPAR as a candidate mediator. These findings provide a basis for further mechanistic and in vivo studies.
SN - 2296-889X
ER -